Related Experiment Video
Updated: Nov 19, 2025

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
MALDI-TOFMS-oriented early definitive therapy improves the optimal use of antibiotics for Enterococcus spp.
Yuki Shimamoto1, Hiroaki Araie2, Kazuhiro Itoh3
1Department of Nephrology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
Abstract:
Enterococci is one of a major cause of bloodstream infection (BSI). Because of its intrinsic drug-resistant nature, empiric antibiotic treatment tends to be inappropriate. We conducted a single-center retrospective cohort study to evaluate the impact of Matrix-assisted laser desorption and ionization time-of-flight mass spectrometry (MALDI-TOFMS) on the improvement of early antibiotic treatment for enterococcal infection. We also investigated the 28-day mortality, length of hospitalization and duration of antibiotic treatment for enterococcal bacteremia. A total of 173 BSI episodes (172 patients) between June 2012 and June 2019 were enrolled. Patients were divided into 2 groups before (n = 82) and after (n = 91) the implementation of MALDI-TOFMS (Control group and MALDI-TOF group, respectively). Almost an equal number of Enterococcus faecalis and Enterococcus faecium cases were identified in each group (51.2% and 48.8%, and 47.3% and 52.7% in each group). By implementing MALDI-TOFMS, the time to definitive antibiotic treatment was significantly improved (median 3 vs 1 days, p < 0.001). The 28-day mortality (29.3% vs 26.4%, p = 0.63) and length of hospitalization (median 16 vs 19 days, p = 0.58) were not significantly different. The duration of antibiotic treatment did not significantly differ between the two groups (median 11 vs 11 days, p = 0.78), but the duration was often shorter in older patients (>74 years old) in MALDI-TOF group, excluding those in the terminal phase of malignancy. By implementing MALDI-TOFMS, the time to definitive antibiotic treatment was significantly shortened. Although associated outcomes did not significantly differ, the duration of antibiotic treatment may be shortened.
Insights
Matrix-assisted laser desorption and ionization time-of-flight mass spectrometry (MALDI-TOFMS) significantly speeds up antibiotic treatment for enterococcal bloodstream infections (BSI). While mortality and hospitalization length remained unchanged, MALDI-TOFMS shows potential for shorter treatment durations.
Area of Science:
- Clinical Microbiology
- Infectious Diseases
- Medical Diagnostics
Background:
- Enterococci are a primary cause of bloodstream infections (BSI).
- Intrinsic drug resistance in enterococci often leads to inappropriate empiric antibiotic therapy.
- Rapid and accurate identification of pathogens is crucial for effective treatment.
Purpose of the Study:
- To evaluate the impact of Matrix-assisted laser desorption and ionization time-of-flight mass spectrometry (MALDI-TOFMS) on early antibiotic treatment for enterococcal infections.
- To investigate the effects of MALDI-TOFMS on 28-day mortality, hospitalization length, and antibiotic treatment duration in patients with enterococcal bacteremia.
Main Methods:
- A single-center retrospective cohort study involving 173 BSI episodes (172 patients) from June 2012 to June 2019.
- Patients were divided into two groups: before (Control group, n=82) and after (MALDI-TOF group, n=91) the implementation of MALDI-TOFMS.
- Comparison of time to definitive antibiotic treatment, 28-day mortality, length of hospitalization, and duration of antibiotic treatment between the groups.
Main Results:
- Implementation of MALDI-TOFMS significantly reduced the time to definitive antibiotic treatment (median 3 days vs. 1 day, p < 0.001).
- No significant differences were observed in 28-day mortality (29.3% vs. 26.4%, p=0.63) or length of hospitalization (median 16 vs. 19 days, p=0.58).
- The duration of antibiotic treatment did not significantly differ (median 11 vs. 11 days, p=0.78), although it tended to be shorter in older patients within the MALDI-TOF group.
Conclusions:
- MALDI-TOFMS significantly accelerates the time to definitive antibiotic treatment for enterococcal bloodstream infections.
- While key clinical outcomes like mortality and hospitalization duration were not significantly altered, the diagnostic speed offers advantages.
- Further research may explore optimizing antibiotic duration based on rapid diagnostics, potentially shortening treatment courses.
More Related Videos
Related Concept Videos
MALDI-TOF Mass Spectrometry
Matrix-assisted laser desorption ionization (MALDI) is a commonly...
Acute Pyelonephritis II: Diagnostic Studies and Management
Endocarditis III: Medical Management
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Antimicrobial Effectiveness
Endocarditis IV: Nursing Management

